Virtus Fund Advisers LLC lowered its position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 3.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,099,946 shares of the company’s stock after selling 42,720 shares during the period. Virtus Fund Advisers LLC’s holdings in Phibro Animal Health were worth $36,848,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Rhumbline Advisers increased its position in shares of Phibro Animal Health by 15.0% during the fourth quarter. Rhumbline Advisers now owns 43,018 shares of the company’s stock worth $1,441,000 after purchasing an additional 5,613 shares in the last quarter. Arizona State Retirement System increased its position in shares of Phibro Animal Health by 229.1% during the fourth quarter. Arizona State Retirement System now owns 32,914 shares of the company’s stock worth $1,103,000 after purchasing an additional 22,914 shares in the last quarter. Eagle Asset Management Inc. increased its position in shares of Phibro Animal Health by 46.5% during the fourth quarter. Eagle Asset Management Inc. now owns 226,123 shares of the company’s stock worth $7,575,000 after purchasing an additional 71,744 shares in the last quarter. Wells Fargo & Company MN increased its position in shares of Phibro Animal Health by 11.0% during the fourth quarter. Wells Fargo & Company MN now owns 102,463 shares of the company’s stock worth $3,433,000 after purchasing an additional 10,137 shares in the last quarter. Finally, First Trust Advisors LP increased its position in shares of Phibro Animal Health by 14.4% during the fourth quarter. First Trust Advisors LP now owns 17,571 shares of the company’s stock worth $589,000 after purchasing an additional 2,212 shares in the last quarter. Institutional investors and hedge funds own 47.38% of the company’s stock.
In other news, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $35.62, for a total transaction of $356,200.00. Following the completion of the sale, the insider now directly owns 10,000 shares in the company, valued at approximately $356,200. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Larry Lee Miller sold 54,572 shares of Phibro Animal Health stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $35.36, for a total transaction of $1,929,665.92. Following the sale, the chief operating officer now owns 8,582 shares of the company’s stock, valued at $303,459.52. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 78,754 shares of company stock valued at $2,789,185. Insiders own 51.88% of the company’s stock.
Shares of Phibro Animal Health Corp (NASDAQ:PAHC) opened at $35.80 on Tuesday. Phibro Animal Health Corp has a twelve month low of $26.70 and a twelve month high of $40.25. The firm has a market capitalization of $1,438.84, a P/E ratio of 22.66, a price-to-earnings-growth ratio of 2.54 and a beta of 1.18. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.75.
Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Monday, February 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The company had revenue of $205.90 million during the quarter, compared to the consensus estimate of $194.90 million. During the same period last year, the firm earned $0.39 EPS. The company’s revenue for the quarter was up 7.5% on a year-over-year basis. equities research analysts forecast that Phibro Animal Health Corp will post 1.69 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, March 6th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health’s payout ratio is 26.14%.
A number of equities analysts recently issued reports on PAHC shares. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. BidaskClub lowered Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Saturday, December 2nd. ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Piper Jaffray Companies reissued a “buy” rating and set a $42.00 price target on shares of Phibro Animal Health in a report on Friday, November 10th. Finally, Credit Suisse Group raised their price target on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a report on Tuesday, February 6th. Three research analysts have rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. Phibro Animal Health has an average rating of “Hold” and an average price target of $38.20.
COPYRIGHT VIOLATION NOTICE: “Virtus Fund Advisers LLC Has $36.85 Million Holdings in Phibro Animal Health Corp (PAHC)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/20/virtus-fund-advisers-llc-has-36-85-million-holdings-in-phibro-animal-health-corp-pahc.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.